FI62316C - Foerfarande foer framstaellning av di- eller trisubstituerade estrar av daunorubicinderivat vilka aer anvaendbara vid behandling av tumoerer - Google Patents
Foerfarande foer framstaellning av di- eller trisubstituerade estrar av daunorubicinderivat vilka aer anvaendbara vid behandling av tumoerer Download PDFInfo
- Publication number
- FI62316C FI62316C FI763251A FI763251A FI62316C FI 62316 C FI62316 C FI 62316C FI 763251 A FI763251 A FI 763251A FI 763251 A FI763251 A FI 763251A FI 62316 C FI62316 C FI 62316C
- Authority
- FI
- Finland
- Prior art keywords
- radical
- formula
- reduced pressure
- under reduced
- chloroform
- Prior art date
Links
- -1 alkyl radicals Chemical class 0.000 claims description 41
- 150000001875 compounds Chemical class 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 20
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 11
- 125000001424 substituent group Chemical group 0.000 claims description 11
- 206010028980 Neoplasm Diseases 0.000 claims description 10
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical class O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 claims description 10
- 150000003254 radicals Chemical class 0.000 claims description 7
- 229910052717 sulfur Inorganic materials 0.000 claims description 7
- 125000004434 sulfur atom Chemical group 0.000 claims description 7
- WSNDAYQNZRJGMJ-UHFFFAOYSA-N 2,2,2-trifluoroethanone Chemical compound FC(F)(F)[C]=O WSNDAYQNZRJGMJ-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 4
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- SDWZXVTWORCAMD-MVGXARHUSA-N 2-[[3-hydroxy-2-methyl-6-[[(1s,3s)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1h-tetracen-1-yl]oxy]oxan-4-yl]amino]acetonitrile Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)C1CC(NCC#N)C(O)C(C)O1 SDWZXVTWORCAMD-MVGXARHUSA-N 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims 3
- 150000001340 alkali metals Chemical group 0.000 claims 3
- AOJDZKCUAATBGE-UHFFFAOYSA-N bromomethane Chemical compound Br[CH2] AOJDZKCUAATBGE-UHFFFAOYSA-N 0.000 claims 2
- QSLPNSWXUQHVLP-UHFFFAOYSA-N $l^{1}-sulfanylmethane Chemical compound [S]C QSLPNSWXUQHVLP-UHFFFAOYSA-N 0.000 claims 1
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical class CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims 1
- 239000000853 adhesive Substances 0.000 claims 1
- 125000006355 carbonyl methylene group Chemical group [H]C([H])([*:2])C([*:1])=O 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 122
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 99
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 84
- 239000000243 solution Substances 0.000 description 58
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 48
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 42
- 239000000203 mixture Substances 0.000 description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 29
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 28
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 26
- 239000002244 precipitate Substances 0.000 description 26
- 239000000741 silica gel Substances 0.000 description 25
- 229910002027 silica gel Inorganic materials 0.000 description 25
- 229910052938 sodium sulfate Inorganic materials 0.000 description 21
- 235000011152 sodium sulphate Nutrition 0.000 description 21
- 239000007787 solid Substances 0.000 description 21
- 241000699670 Mus sp. Species 0.000 description 20
- 239000000706 filtrate Substances 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 239000011541 reaction mixture Substances 0.000 description 17
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 14
- 239000012265 solid product Substances 0.000 description 14
- 229960000975 daunorubicin Drugs 0.000 description 12
- 229960003109 daunorubicin hydrochloride Drugs 0.000 description 12
- LYBCHMBMGSZNOA-UHFFFAOYSA-N dichloromethane;formic acid;methanol Chemical compound OC.OC=O.ClCCl LYBCHMBMGSZNOA-UHFFFAOYSA-N 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 229920006395 saturated elastomer Polymers 0.000 description 11
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 9
- 239000012074 organic phase Substances 0.000 description 9
- 238000007796 conventional method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 125000004430 oxygen atom Chemical group O* 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- KQRWYZDETCDVGB-TZSSRYMLSA-N (7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-(2-bromoacetyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CBr)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 KQRWYZDETCDVGB-TZSSRYMLSA-N 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 208000032839 leukemia Diseases 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 4
- 239000005909 Kieselgur Substances 0.000 description 4
- 208000008342 Leukemia P388 Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 238000005893 bromination reaction Methods 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 230000031709 bromination Effects 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- IWYBVQLPTCMVFO-UHFFFAOYSA-N ethyl 2,2-dichloroacetate Chemical compound CCOC(=O)C(Cl)Cl IWYBVQLPTCMVFO-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- OHISWSXKWZMJIC-UHFFFAOYSA-M sodium;2,2-diethoxyacetate Chemical compound [Na+].CCOC(C([O-])=O)OCC OHISWSXKWZMJIC-UHFFFAOYSA-M 0.000 description 3
- NAALWFYYHHJEFQ-ZASNTINBSA-N (2s,5r,6r)-6-[[(2r)-2-[[6-[4-[bis(2-hydroxyethyl)sulfamoyl]phenyl]-2-oxo-1h-pyridine-3-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC(O)=CC=1)C(=O)C(C(N1)=O)=CC=C1C1=CC=C(S(=O)(=O)N(CCO)CCO)C=C1 NAALWFYYHHJEFQ-ZASNTINBSA-N 0.000 description 2
- XNIHZNNZJHYHLC-UHFFFAOYSA-M 2-oxohexanoate Chemical compound CCCCC(=O)C([O-])=O XNIHZNNZJHYHLC-UHFFFAOYSA-M 0.000 description 2
- XFSOVHHLFWJNFW-UHFFFAOYSA-M C(C)(=O)O.CC1=CC=C(S[Na])C=C1 Chemical compound C(C)(=O)O.CC1=CC=C(S[Na])C=C1 XFSOVHHLFWJNFW-UHFFFAOYSA-M 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- TWNSXPRRBKLPOK-UHFFFAOYSA-N dichloromethane formic acid methanol hydrate Chemical compound O.OC.OC=O.ClCCl TWNSXPRRBKLPOK-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- WQICLNAJOMHDSF-UHFFFAOYSA-N ethyl 1,3-dioxolane-2-carboxylate Chemical compound CCOC(=O)C1OCCO1 WQICLNAJOMHDSF-UHFFFAOYSA-N 0.000 description 2
- XCLBIKIQSCTANZ-UHFFFAOYSA-N ethyl 2,2-diethoxyacetate Chemical compound CCOC(OCC)C(=O)OCC XCLBIKIQSCTANZ-UHFFFAOYSA-N 0.000 description 2
- BVAMIFTXHAJQHP-UHFFFAOYSA-N ethyl 2,2-diethoxypropanoate Chemical compound CCOC(=O)C(C)(OCC)OCC BVAMIFTXHAJQHP-UHFFFAOYSA-N 0.000 description 2
- ALLYWZMKKLTYGF-UHFFFAOYSA-N ethyl 2-phenyl-1,3-dithiolane-2-carboxylate Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)SCCS1 ALLYWZMKKLTYGF-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 150000002688 maleic acid derivatives Chemical class 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- NBRXRGHQBPRZQM-UHFFFAOYSA-M sodium;1,3-dithiane-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1SCCCS1 NBRXRGHQBPRZQM-UHFFFAOYSA-M 0.000 description 2
- YWQHJJFJHGWVMF-UHFFFAOYSA-M sodium;1,3-dithiolane-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1SCCS1 YWQHJJFJHGWVMF-UHFFFAOYSA-M 0.000 description 2
- JNSCQGRGFXEOKN-UHFFFAOYSA-M sodium;1,3-oxathiolane-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1OCCS1 JNSCQGRGFXEOKN-UHFFFAOYSA-M 0.000 description 2
- IHVOFYMCUAWASQ-UHFFFAOYSA-M sodium;2,2-dibutoxyacetate Chemical compound [Na+].CCCCOC(C([O-])=O)OCCCC IHVOFYMCUAWASQ-UHFFFAOYSA-M 0.000 description 2
- NDAPQUMKKWVGTE-UHFFFAOYSA-M sodium;2,2-diphenoxyacetate Chemical compound [Na+].C=1C=CC=CC=1OC(C(=O)[O-])OC1=CC=CC=C1 NDAPQUMKKWVGTE-UHFFFAOYSA-M 0.000 description 2
- UAWSQDMOSLSOTR-UHFFFAOYSA-M sodium;2,2-diphenylethanethioate Chemical compound [Na+].C=1C=CC=CC=1C(C(=S)[O-])C1=CC=CC=C1 UAWSQDMOSLSOTR-UHFFFAOYSA-M 0.000 description 2
- ZYRRWVSJBRGUKR-UHFFFAOYSA-M sodium;2-phenyl-1,3-dithiolane-2-carboxylate Chemical compound [Na+].C=1C=CC=CC=1C1(C(=O)[O-])SCCS1 ZYRRWVSJBRGUKR-UHFFFAOYSA-M 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000001935 tetracenyl group Chemical class C1(=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C12)* 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- NXUBLCILQTXVGB-UHFFFAOYSA-N 1,3-dioxolane-2-carboxylic acid Chemical compound OC(=O)C1OCCO1 NXUBLCILQTXVGB-UHFFFAOYSA-N 0.000 description 1
- BZBYEAWKJNCPLB-UHFFFAOYSA-N 1,3-dithiane-2-carboxylic acid Chemical compound OC(=O)C1SCCCS1 BZBYEAWKJNCPLB-UHFFFAOYSA-N 0.000 description 1
- DSOVOUOPKYLGID-UHFFFAOYSA-N 1,3-dithiolane-2-carboxylic acid Chemical compound OC(=O)C1SCCS1 DSOVOUOPKYLGID-UHFFFAOYSA-N 0.000 description 1
- DTLTUUJDCNTTSN-UHFFFAOYSA-N 1,4-dioxane;molecular bromine Chemical compound BrBr.C1COCCO1 DTLTUUJDCNTTSN-UHFFFAOYSA-N 0.000 description 1
- WFVKIANRKSZMGB-UHFFFAOYSA-N 2,2-diethoxyacetic acid Chemical compound CCOC(C(O)=O)OCC WFVKIANRKSZMGB-UHFFFAOYSA-N 0.000 description 1
- SFTDDFBJWUWKMN-UHFFFAOYSA-N 2-(4-methylphenoxy)acetic acid Chemical compound CC1=CC=C(OCC(O)=O)C=C1 SFTDDFBJWUWKMN-UHFFFAOYSA-N 0.000 description 1
- XCRDQVBOVYWDPH-UHFFFAOYSA-N 2-(4-methylphenyl)sulfanylacetic acid Chemical compound CC1=CC=C(SCC(O)=O)C=C1 XCRDQVBOVYWDPH-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WLHCBQAPPJAULW-UHFFFAOYSA-N 4-methylbenzenethiol Chemical compound CC1=CC=C(S)C=C1 WLHCBQAPPJAULW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- PCQBEDOXTJROHD-UHFFFAOYSA-N C(C)(=O)OCC.CC=1C=CSC1 Chemical compound C(C)(=O)OCC.CC=1C=CSC1 PCQBEDOXTJROHD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241001480079 Corymbia calophylla Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- 208000007093 Leukemia L1210 Diseases 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- LEQXXBBCRATLPW-UHFFFAOYSA-N butyl 2,2-dibutoxyacetate Chemical compound CCCCOC(OCCCC)C(=O)OCCCC LEQXXBBCRATLPW-UHFFFAOYSA-N 0.000 description 1
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- RGISQTYPQCDWMB-UHFFFAOYSA-N ethyl 2,2-diphenoxyacetate Chemical compound C=1C=CC=CC=1OC(C(=O)OCC)OC1=CC=CC=C1 RGISQTYPQCDWMB-UHFFFAOYSA-N 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 231100000008 high dose toxicity Toxicity 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910000462 iron(III) oxide hydroxide Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- GPKUICFDWYEPTK-UHFFFAOYSA-N methoxycyclohexatriene Chemical compound COC1=CC=C=C[CH]1 GPKUICFDWYEPTK-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- YKJZGXPFJUXCFW-UHFFFAOYSA-N o-ethyl 2,2-diphenylethanethioate Chemical compound C=1C=CC=CC=1C(C(=S)OCC)C1=CC=CC=C1 YKJZGXPFJUXCFW-UHFFFAOYSA-N 0.000 description 1
- ZRBGVGLMYGACRC-UHFFFAOYSA-N o-ethyl 2-ethylbutanethioate Chemical compound CCOC(=S)C(CC)CC ZRBGVGLMYGACRC-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- ZJRUCAUSFOHSBM-UHFFFAOYSA-M sodium;1,3-dioxolane-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1OCCO1 ZJRUCAUSFOHSBM-UHFFFAOYSA-M 0.000 description 1
- HHHWOLOSZIFATL-UHFFFAOYSA-M sodium;2,2-diethoxypropanoate Chemical compound [Na+].CCOC(C)(C([O-])=O)OCC HHHWOLOSZIFATL-UHFFFAOYSA-M 0.000 description 1
- ZUWPVRLSKDCHMJ-UHFFFAOYSA-M sodium;2-ethylbutanethioate Chemical compound [Na+].CCC(CC)C([O-])=S ZUWPVRLSKDCHMJ-UHFFFAOYSA-M 0.000 description 1
- PGOLCPKOJMABCK-UHFFFAOYSA-M sodium;acetic acid;4-methylphenolate Chemical compound [Na+].CC(O)=O.CC1=CC=C([O-])C=C1 PGOLCPKOJMABCK-UHFFFAOYSA-M 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- ZNEOHLHCKGUAEB-UHFFFAOYSA-N trimethylphenylammonium Chemical compound C[N+](C)(C)C1=CC=CC=C1 ZNEOHLHCKGUAEB-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7534450 | 1975-11-12 | ||
| FR7534450A FR2331351A1 (fr) | 1975-11-12 | 1975-11-12 | Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent |
| FR7628977 | 1976-09-27 | ||
| FR7628978A FR2365346A2 (fr) | 1976-09-27 | 1976-09-27 | Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent |
| FR7628977A FR2365345A2 (fr) | 1976-09-27 | 1976-09-27 | Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent |
| FR7628978 | 1976-09-27 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI763251A FI763251A (hu) | 1977-05-13 |
| FI62316B FI62316B (fi) | 1982-08-31 |
| FI62316C true FI62316C (fi) | 1982-12-10 |
Family
ID=27250546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI763251A FI62316C (fi) | 1975-11-12 | 1976-11-12 | Foerfarande foer framstaellning av di- eller trisubstituerade estrar av daunorubicinderivat vilka aer anvaendbara vid behandling av tumoerer |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4225589A (hu) |
| JP (1) | JPS5285161A (hu) |
| AR (1) | AR213419A1 (hu) |
| AT (1) | AT347583B (hu) |
| AU (1) | AU504388B2 (hu) |
| CA (1) | CA1072954A (hu) |
| CH (1) | CH606081A5 (hu) |
| CS (1) | CS209876B2 (hu) |
| DE (1) | DE2651773C3 (hu) |
| DK (1) | DK508776A (hu) |
| ES (1) | ES453264A1 (hu) |
| FI (1) | FI62316C (hu) |
| GB (1) | GB1525180A (hu) |
| HU (1) | HU172526B (hu) |
| IL (1) | IL50897A (hu) |
| LU (1) | LU76176A1 (hu) |
| NL (1) | NL170737C (hu) |
| NO (1) | NO143349C (hu) |
| NZ (1) | NZ182591A (hu) |
| PH (1) | PH13709A (hu) |
| SE (1) | SE421212B (hu) |
| SU (1) | SU659095A3 (hu) |
| YU (1) | YU277876A (hu) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2430425A1 (fr) * | 1978-07-07 | 1980-02-01 | Rhone Poulenc Ind | Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| JPS56156300A (en) * | 1980-04-26 | 1981-12-02 | Microbial Chem Res Found | Novel preparative method of anthracyclin derivative |
| GB2169285A (en) * | 1985-01-05 | 1986-07-09 | Erba Farmitalia | 4'-Deoxydoxorubicin-14-esters |
| GB2169284A (en) * | 1985-01-05 | 1986-07-09 | Erba Farmitalia | 4'-Epidoxorubicin-14-esters |
| GB2169286A (en) * | 1985-01-05 | 1986-07-09 | Erba Farmitalia | 4'-Deoxy-4'-halodoxorubicin-14-esters |
| US7388083B2 (en) * | 2005-03-07 | 2008-06-17 | Solux Corporation | Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics |
| US8802830B2 (en) * | 2005-12-20 | 2014-08-12 | Solux Corporation | Synthesis of epirubicin from 13-dihydrodaunorubicine |
| US8357785B2 (en) * | 2008-01-08 | 2013-01-22 | Solux Corporation | Method of aralkylation of 4′-hydroxyl group of anthracylins |
| FR2986706B1 (fr) * | 2012-02-09 | 2015-09-18 | Oreal | Composition comprenant un (thio)acetal ou un hemi(thio)acetal d'acide glyoxylique et procede de traitement cosmetique |
| WO2013117771A2 (en) * | 2012-02-09 | 2013-08-15 | L'oreal | Cosmetic treatment method, and composition comprising a glyoxylic acid derivative |
| CN108484689B (zh) * | 2018-03-06 | 2020-11-10 | 道中道（菏泽）制药有限公司 | 一种戊柔比星合成方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1499026A (en) * | 1975-06-20 | 1978-01-25 | Farmaceutici Italia | Adriamycin esters |
-
1976
- 1976-11-04 NL NLAANVRAGE7612239,A patent/NL170737C/xx not_active IP Right Cessation
- 1976-11-08 CA CA265,119A patent/CA1072954A/en not_active Expired
- 1976-11-09 CS CS767234A patent/CS209876B2/cs unknown
- 1976-11-09 SU SU762418213A patent/SU659095A3/ru active
- 1976-11-10 PH PH19114A patent/PH13709A/en unknown
- 1976-11-10 GB GB46807/76A patent/GB1525180A/en not_active Expired
- 1976-11-10 NZ NZ182591A patent/NZ182591A/xx unknown
- 1976-11-10 AU AU19506/76A patent/AU504388B2/en not_active Expired
- 1976-11-10 JP JP13510676A patent/JPS5285161A/ja active Granted
- 1976-11-11 IL IL50897A patent/IL50897A/xx unknown
- 1976-11-11 AR AR265428A patent/AR213419A1/es active
- 1976-11-11 DK DK508776A patent/DK508776A/da unknown
- 1976-11-11 NO NO763857A patent/NO143349C/no unknown
- 1976-11-11 HU HU76RO00000903A patent/HU172526B/hu not_active IP Right Cessation
- 1976-11-11 LU LU76176A patent/LU76176A1/xx unknown
- 1976-11-11 CH CH1423376A patent/CH606081A5/xx not_active IP Right Cessation
- 1976-11-11 SE SE7612613A patent/SE421212B/xx not_active IP Right Cessation
- 1976-11-12 DE DE2651773A patent/DE2651773C3/de not_active Expired
- 1976-11-12 ES ES453264A patent/ES453264A1/es not_active Expired
- 1976-11-12 FI FI763251A patent/FI62316C/fi not_active IP Right Cessation
- 1976-11-12 AT AT842876A patent/AT347583B/de active
- 1976-11-12 YU YU02778/76A patent/YU277876A/xx unknown
-
1977
- 1977-11-09 US US05/849,761 patent/US4225589A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI763251A (hu) | 1977-05-13 |
| HU172526B (hu) | 1978-09-28 |
| US4225589A (en) | 1980-09-30 |
| NO763857L (hu) | 1977-05-13 |
| NZ182591A (en) | 1978-06-02 |
| LU76176A1 (hu) | 1977-06-03 |
| NO143349B (no) | 1980-10-13 |
| IL50897A (en) | 1979-11-30 |
| AU504388B2 (en) | 1979-10-11 |
| CA1072954A (en) | 1980-03-04 |
| DK508776A (da) | 1977-05-13 |
| SE421212B (sv) | 1981-12-07 |
| IL50897A0 (en) | 1977-01-31 |
| DE2651773B2 (de) | 1979-06-13 |
| NL7612239A (nl) | 1977-05-16 |
| SU659095A3 (ru) | 1979-04-25 |
| ES453264A1 (es) | 1978-05-01 |
| AR213419A1 (es) | 1979-01-31 |
| NL170737B (nl) | 1982-07-16 |
| GB1525180A (en) | 1978-09-20 |
| AU1950676A (en) | 1978-05-18 |
| ATA842876A (de) | 1978-05-15 |
| NL170737C (nl) | 1982-12-16 |
| PH13709A (en) | 1980-09-09 |
| JPS5426529B2 (hu) | 1979-09-04 |
| DE2651773A1 (de) | 1977-05-18 |
| CH606081A5 (hu) | 1978-10-13 |
| CS209876B2 (en) | 1981-12-31 |
| FI62316B (fi) | 1982-08-31 |
| JPS5285161A (en) | 1977-07-15 |
| NO143349C (no) | 1981-01-21 |
| SE7612613L (sv) | 1977-05-13 |
| DE2651773C3 (de) | 1980-02-07 |
| AT347583B (de) | 1979-01-10 |
| YU277876A (en) | 1982-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI62316C (fi) | Foerfarande foer framstaellning av di- eller trisubstituerade estrar av daunorubicinderivat vilka aer anvaendbara vid behandling av tumoerer | |
| DK147304B (da) | Analogifremgangsmaade til fremstilling af (-) daunosaminyl-4-demethoxydaunomycinon som en blanding af (7s : 9r) og (7r : 9r) alfa-anomere | |
| SE435514B (sv) | Forfarande for framstellning av 4'-deoxiadriamycin hydroklorid | |
| US4031211A (en) | Adriamycin esters, their preparation and use | |
| US4859782A (en) | Misakinolide compositions and their derivatives | |
| US4708962A (en) | Antiviral and antitumor cyclohexadienone compositions | |
| US4232023A (en) | Novel soluble derivatives of 2,4-diamino pyrimidine | |
| US4410459A (en) | Process for preparation of cytostatic compounds | |
| CN101654401A (zh) | 不对称联苯类化合物、含有它的药物组合物及其用途 | |
| FI76574B (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla ribofuranosylselenazol-4-karboxamidfoereningar, deras mellanprodukt och dess framstaellning. | |
| EP0272810A2 (en) | Antitumor and antiviral alkaloids | |
| ZA200502226B (en) | Sorbicillactone-A derivatives for the treatment oftumour and viral diseases. | |
| SU1251806A3 (ru) | Способ получени 7-замещенных 9а-метоксимитозана | |
| EP0299713B1 (en) | Antiviral, antitumor and antifungal compositions | |
| JP2991348B2 (ja) | ７−（ジフェニルメチル）オキシ−９ａ−メトキシマイトサン並びにその製造及び使用 | |
| US5741813A (en) | Compounds for the treatment of hepatoma | |
| EP0124379A1 (en) | Hydroquinone derivatives and production thereof | |
| Scannell et al. | Synthesis of the angular furanoxanthone, deoxydehydropsorospermin methyl ether (5, 10‐dimethoxy‐2‐isopropenyl‐6H‐furo [2, 3‐c] xanthen‐6‐one) | |
| CA1257281A (en) | Antiviral and anti-tumor cyclohexadienone compositions | |
| US4576945A (en) | Hexaalkylmelamine-amino-oxy compounds | |
| IE42132B1 (en) | Novel derivatives of vinblastine,vincristine and leurosidine | |
| US4921873A (en) | Antiviral and antitumor cyclohexadienone compositions | |
| DK147069B (da) | Analogifremgangsmaade til fremstilling af 1,6-dimesyl-3,4-dimethyl-d-mannitol | |
| GB2086378A (en) | Process for the Preparation of Cytostatic Compounds | |
| FI67845C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara xylitolderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: RHONE- POULENC INDUSTRIES |